Reliq Health Technologies Begins $7.5 Million Brokered Private Placement, Co-led by Canaccord Genuity and Gravitas Securities

Reliq Health Technologies Inc. (TSXV:RHT) will be working with Canaccord Genuity Corp. (TSXV:CF) and Gravitas Securities Inc. (private) on a brokered private placement offering. Canaccord and Gravitas will be co-leading the private placement, which will consist of up to 6,696,428 units at $1.12 per unit, totaling $7.5 million.

Each unit will be made up of one common share in the company and half a transferable common share purchase warrant. Each warrant can acquire an additional share for $1.75 for up to two years after the closing date. The funds from the private placement will be used for general working capital, product development, and customer acquisition.

The CEO of Reliq Health, Lisa Crossley, has said of the agreement, “We are pleased to have the continued support of two of Canada’s leading independent brokerage firms.”

Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) Market Jar Media Inc. has or expects to receive the following amounts indirectly from the following companies mentioned in this Article: Reliq Health Technologies Inc. Click here for important disclosures about fees.

3) The Article and content related to the profiled company represent the personal and subjective views of the Author of this article, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, Market Jar Media Inc. or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The author was paid by Native Ads Inc. for this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'ss terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Market Jar Media Inc. should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Market Jar Media Inc.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.

STOCKS YOU MAY LIKE